New England Journal of Medicine · 1973 · 196 citations · 12 references
MedicinePharmacologyPsychiatryGeriatric PsychiatryNeuropharmacologyPsychopharmacologyAnxiety Disorder PharmacotherapyAnxiolytic PharmacotherapyAnxiolytic Use DisordersTobacco DependenceBenzodiazepine TreatmentCigarette Smoking PrevalenceCns DepressionDepression Pathophysiology
Frequencies of clinical depression of the central nervous system (CNS), as indicated by drowsiness attributable to drugs were compared among nonsmokers, light smokers (20 cigarettes per day or less), and heavy smokers who received diazepam, chlordiazepoxide, or phenobarbital for anxiety. With the two benzodiazepines, CNS depression was less common the greater the number of cigarettes smoked. This trend was not evident with phenobarbital. CNS depression attributed to the benzodiazepines became more common with increasing age. The age trend was also not evident in patients who received phenobarbital. Increased benzodiazepine metabolism in cigarette smokers and decreased metabolism in older patients may explain these findings.
12
Effect of Age and Sex on Human Drug Metabolism
K O'Malley, J. Crooks, Ian H. Stevenson · BMJ · 1971 · 383 citations · Full text
Richard M. Welch, Y. E. Harrison, B. W. Gommi et al. · Clinical Pharmacology & Therapeutics · 1969 · 167 citations
Pharmacy, Obstetrics, Toxicology +15